Mark Sheptoff Financial Planning, LLC Genmab A/S Transaction History
Mark Sheptoff Financial Planning, LLC
- $180 Million
- Q2 2025
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Genmab A/S stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 1,400 shares of GMAB stock, worth $40,054. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,400
Previous 1,400
-0.0%
Holding current value
$40,054
Previous $27,000
3.7%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding GMAB
# of Institutions
252Shares Held
65.2MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$305 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$227 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$145 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$102 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$98.8 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $18.8B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...